DEU9SAD

Due to market price fluctuations, if you need to purchase or consult the price. You can contact us or emial to us:   sales@allicdata.com

DEU9SAD, or Differential Endpoint Ultrasound-Based 9-DoF Simulator for Assessment of Drug, is a revolutionary drug assessment tool used in the drug development process. The tool enables drug developers to simulate the effects of a drug on a 9-DoF human musculoskeletal system. It is a combination of two existing technologies: ultrasound and an inverse dynamics-based simulation technique.DEU9SAD is designed to help identify adverse events and potential safety issues with a newly developed drug during pre-clinical and clinical trials. The technique can accurately predict a drug’s effects on a human joint and the surrounding anatomy. It can also identify potential drug-induced muscle- and joint-related injuries and disorders, such as arthritis, tendinopathy, and muscle tears.At the heart of DEU9SAD is its high-resolution imaging ultrasound. This technology captures data in real-time from a three-dimensional target area of the human anatomy. This data is transduced into a “virtual anatomical model” of the target area, enabling precise and accurate evaluation of the individual’s musculoskeletal structure.The depth of the imaging is also important as it allows for the measurement of more surface and deeper structures within the joint. This enables the creation of more realistic, three-dimensional models and simulations. The data is also converted into three-dimensional displacement-time curves, giving an accurate picture of the joint’s movements.The next component of DEU9SAD is its inverse dynamics-based simulation. This simulation is used to predict the effect the drug will have on the joint’s movements. This is done by analyzing the displacement-time curves of the joint and finding “realistic” conditions for drug-induced effects. Through this simulation, the drug developer can assess the drug’s effects on the patient’s joint in a virtual setting.The simulation creates a “virtual” three-dimensional “state of the joint” and a three-dimensional surface topography model. This model can be used to calculate forces, torques, and moments of various muscle groups. From this, the causal forces driving the joint movement are determined and the impact of the drug on the muscle and joint is assessed.In addition to the ultrasound and simulation, the system uses electrogoniometers and accelerometers to measure angles of movement and speed. These sensors provide real-time data on muscle activity, joint motion, and joint stability. This allows for a more accurate assessment of the drug’s impact on the joint and its surrounding anatomy.The combination of all of these technologies provides a comprehensive assessment of the drug’s efficacy and safety. With the data collected, projected outcomes of the drug can be accurately predicted. This system can also be adapted and used in various medical procedures, such as robotic-assisted surgery, rehabilitation, and sports medicine.Overall, DEU9SAD is a revolutionary tool for assessing a drug’s effects on the musculoskeletal system. It provides a comprehensive view of the joint, allowing drug developers to accurately predict the drug’s effects. It also eliminates guesswork and reduces the time it takes to assess a drug’s efficacy and safety. With the combination of ultrasound and simulation-based technologies, it is an invaluable tool in the drug development process.

The specific data is subject to PDF, and the above content is for reference